Fink Jeffrey Arvin 4
4 · Lipocine Inc. · Filed Jun 7, 2024
Insider Transaction Report
Form 4
Lipocine Inc.LPCN
Fink Jeffrey Arvin
Director
Transactions
- Award
Common Stock (Right to Buy)
2024-06-05$7.05/sh+1,764$12,436→ 10,938 totalExercise: $7.05From: 2025-06-05Exp: 2034-06-05→ Common Stock (1,764 underlying)